Antidepressant combination and potentiation
- PMID: 2017568
Antidepressant combination and potentiation
Abstract
This chapter will describe the clinical indications and safety/efficacy factors of antidepressant potentiation. Examples include TCA/MAOI combinations, MAOI/stimulant combination, antidepressant potentiation with thyroid, lithium or l-tryptophan.
Similar articles
-
Augmentation strategies in patients with refractory depression.Depress Anxiety. 1996-1997;4(4):169-81. doi: 10.1002/(SICI)1520-6394(1996)4:4<169::AID-DA3>3.0.CO;2-A. Depress Anxiety. 1996. PMID: 9166649 Review.
-
Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.J Clin Psychiatry. 1985 Jun;46(6):206-9. J Clin Psychiatry. 1985. PMID: 3997787
-
[Lithium in the treatment of refractory depression].Encephale. 1993 Sep-Oct;19(5):553-64. Encephale. 1993. PMID: 8306924 Review. French.
-
CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.J Clin Psychopharmacol. 1991 Apr;11(2):127-32. J Clin Psychopharmacol. 1991. PMID: 2056139
-
Innovative somatic treatments for depression.Psychiatr Med. 1991;9(1):77-103. Psychiatr Med. 1991. PMID: 2017569 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical